U.S. Oil and Gas Stock News

Why One Stop Systems is attracting fresh attention One Stop Systems (OSS) is back in focus after reporting full year 2025 results that shifted from a prior net loss to net income, alongside guidance calling for 20% to 25% revenue growth in 2026. See our latest analysis for One Stop Systems. Despite the strong 2025 results and new 2026 guidance, the recent 15.4% 7-day share price decline and 7.0% 30-day share price return contrast with a 231.1% 1-year total shareholder return, suggesting...

Willis Towers Watson (NasdaqGS:WTW) appointed a new global leader for its Work & Rewards business, signaling a refresh in a key advisory unit. The company launched an art insurance facility for collectors and galleries in Asia through a partnership focused on regional specialty coverage. Insurtech firm Thimble adopted WTW’s Radar Live platform to support modernized pricing for commercial lines. WTW shares trade at $293.36, with a value score of 2 and a mixed return profile that includes a...

If you are wondering whether Tenet Healthcare at around US$199.63 is still offering value or has already priced in its story, this breakdown is for you. The stock has recently seen a 5.7% decline over the last 7 days and a 13.2% decline over the last 30 days, while the 1 year return of 52.6% and very large 3 year and 5 year returns keep longer term holders focused. Recent headlines have focused on Tenet Healthcare as investors reassess hospital and healthcare operators, with attention on how...

Wondering if TransMedics Group at around US$108.92 is priced for its future potential or already reflecting high expectations? This article breaks down what the current share price might be implying about the company. The stock has seen a 12.7% decline over the past week and an 18.9% decline over the last 30 days, even though the 1 year return sits at 53.9% and the 3 year return at 45.8%. Recent coverage has focused on TransMedics Group's position in the medical technology space and what its...

If you are wondering whether Merit Medical Systems at around US$67.55 is starting to look appealing or still feels expensive, the recent share performance gives you a useful starting point. The stock has seen a 3.8% decline over the last 7 days, a 17.8% fall over the last 30 days, and is down 21.9% year to date and 35.5% over the past year, while the 5 year return stands at 13.4%. These moves have put more attention on how the market currently prices Merit Medical Systems and whether...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

Over the last 7 days, the United States market has dropped 2.3%, but it has experienced a 13% rise over the past year, with earnings forecast to grow by 16% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability in an evolving market landscape.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential long-term gains amidst fluctuating market conditions.

The recent 13% drop in Indaptus Therapeutics, Inc.'s ( NASDAQ:INDP ) stock could come as a blow to insiders who...

Over the last 7 days, the United States market has dropped 2.3%, yet it has risen by 13% over the past year, with earnings forecasted to grow by 16% annually. In this context of fluctuating short-term performance and promising long-term growth prospects, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations and future potential.

Sumitomo Mitsui Financial Group is reportedly exploring a potential takeover of Jefferies Financial Group, NYSE:JEF. Media reports indicate preliminary discussions and a gradual stake build since 2021, although no formal offer has been announced. Jefferies' management has publicly stated there are no active negotiations, keeping the situation in a speculative phase. For investors watching NYSE:JEF at a current share price of $40.55, the takeover speculation comes against a mixed performance...

Over the last 7 days, the U.S. market has dropped by 2.3%, though it has shown a robust increase of 13% over the past year, with earnings projected to grow by 16% annually in the coming years. In such fluctuating conditions, identifying stocks with strong fundamentals and solid balance sheets can be crucial for investors seeking growth opportunities at lower price points. Penny stocks, often representing smaller or newer companies, continue to present underappreciated potential for growth and...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks with strong fundamentals and growth potential can be key to uncovering promising opportunities in an evolving market landscape.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it has shown resilience with a 13% rise over the past year and earnings are expected to grow by 16% annually. In such dynamic conditions, dividend stocks can offer investors stability and income potential, making them an attractive option for those seeking steady returns amidst market fluctuations.

Insiders who bought US$1.73m worth of Cartesian Therapeutics, Inc.'s ( NASDAQ:RNAC ) stock at an average buy price of...

Even if it's not a huge purchase, we think it was good to see that Douglas Reynolds, the President of Energy Services...

We feel now is a pretty good time to analyse CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) business as it appears...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

On March 10, Centrus Energy (NYSE:LEU) adopted amended bylaws addressing new universal proxy rules. The changes clarify shareholder voting standards and tighten requirements for using universal proxy cards in director elections. The board also updated exclusive forum provisions that govern where certain legal disputes must be brought. Centrus Energy is drawing fresh attention after its board revised the company bylaws to align with evolving proxy and legal frameworks. The move comes as the...

We wouldn't blame Viemed Healthcare, Inc. ( NASDAQ:VMD ) shareholders if they were a little worried about the fact that...

On March 23, 2026, shareholder advocate John Chevedden submitted a proposal asking ICU Medical’s board to amend its governing documents so that investors holding at least 10% of outstanding common stock, or the lowest threshold allowed under state law, can call a special shareholder meeting. This push to lower the hurdle for convening special meetings highlights investor interest in stronger governance rights and potentially greater influence over future corporate decisions at ICU...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

The Morning Bull - US Market Morning Update Wednesday, Mar, 25 2026 US stock futures are pointing higher this morning, with key contracts on the S&P 500 and Nasdaq up around 1%, as investors weigh easing tensions in the Middle East against stubbornly high borrowing costs. The US 10 year Treasury yield is sitting above 4.4%, an eight month high, which means mortgages, car loans and business financing remain expensive. At the same time, fresh US business surveys show manufacturing at 52.4 and...

Wondering whether Box at US$23.60 offers good value or if you are better off waiting on the sidelines? This breakdown will help you see how the current price compares with a range of valuation checks. The share price has been mixed recently, with a 3.5% decline over the last week, a 3.2% gain over the last month, and returns of an 18.1% decline year to date and a 23.3% decline over the last year. Recent headlines around Box have focused on its position in content management and collaboration...